2019
DOI: 10.1159/000499647
|View full text |Cite
|
Sign up to set email alerts
|

Use of Both Serum Cystatin C and Creatinine as Diagnostic Criteria for Cardiac Surgery-Associated Acute Kidney Injury and Its Correlation with Long-Term Major Adverse Events

Abstract: Background/Aims: Cardiac surgery-associated acute kidney injury (CSA-AKI) was traditionally defined as an increase in serum creatinine (sCr) after cardiac surgery. Recently, serum cystatin C (sCyC) has been proposed to be a better biomarker in the prediction of AKI. The clinical utility and performance of combining sCyC and sCr in patients with AKI, particularly for the prediction of long-term outcomes, remain unknown. Methods: We measured sCyC together with sCr in 628 patients undergoing cardiac surgery. sCyC… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
2
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 26 publications
2
2
1
Order By: Relevance
“…Several studies were in agreement with our findings that CysC is useful for diagnosis (Murty et al, 2013;Deng et al, 2017) and prediction (Herget-Rosenthal et al, 2004b;Åhlström et al, 2004) of AKI in critically ill patients in variable age groups, whether associated with sepsis or with another clinical setting (Che et al, 2019), regardless of the underlying precipitating factors. In the same context, a multicenter comparative study of several biomarkers reported that sCysC was the best diagnostic biomarker of AKI in comparison to both urinary N-acetylβ-D-glucosaminidase and albumin/creatinine ratio, as AUC increased with the progression and severity of AKI (AUC for AKI and severe septic AKI was 0.738 and 0.839).…”
Section: Discussionsupporting
confidence: 91%
“…Several studies were in agreement with our findings that CysC is useful for diagnosis (Murty et al, 2013;Deng et al, 2017) and prediction (Herget-Rosenthal et al, 2004b;Åhlström et al, 2004) of AKI in critically ill patients in variable age groups, whether associated with sepsis or with another clinical setting (Che et al, 2019), regardless of the underlying precipitating factors. In the same context, a multicenter comparative study of several biomarkers reported that sCysC was the best diagnostic biomarker of AKI in comparison to both urinary N-acetylβ-D-glucosaminidase and albumin/creatinine ratio, as AUC increased with the progression and severity of AKI (AUC for AKI and severe septic AKI was 0.738 and 0.839).…”
Section: Discussionsupporting
confidence: 91%
“…CysC is an alternative kidney function biomarker to SCr with potentially superior diagnostic properties such as faster kinetics and independence from muscle mass. Consistent with data from different clinical contexts, including AKI after cardiac surgery, CysC also showed promising performance in the postoperative prediction of AKI II/III in our study ( 29–31 ).…”
Section: Discussionsupporting
confidence: 90%
“…In comparing serum cystatin C and serum creatinine values in patients undergoing cardiac surgery, a rise of more than or equal to 30 % baseline serum cystatin C was considered to be suggestive of AKI. 20 In our study, none of the patients demonstrated such an increase. In our study, both the creatinine and cystatin C are found to point toward a normal physiological limit meaning that there is no predisposition to AKI by infusion of the study fluids.…”
Section: Discussioncontrasting
confidence: 54%